Logo 1 Logo 2

Clinical Trial Details

Trial ID: L6392
Source ID: NCT03317028
Associated Drug: Cs02 Tablet And Placebo Tablet
Title: CS02 vs Placebo With Metformin in Type 2 Diabetes Mellitus (T2DM)
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: T2DM With Inadequate Glycemic Control
Interventions: DRUG: CS02 tablet and placebo tablet
Outcome Measures: Primary: The HbA1c treatment effect among CS02 groups and the Placebo group, To assess 208 evaluable subject of the change in HbA1c from baseline to end of treatment among CS02 groups and CS02 placebo to match group will be compared with the analysis of covariance model including baseline HbA1c as covariate, and treatment groups and regions as fixed effects., 12 weeks |
Sponsor/Collaborators: Sponsor: Center Laboratories, Inc.
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE2
Enrollment: 201
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Start Date: 2017-10-10
Completion Date: 2020-04-21
Results First Posted:
Last Update Posted: 2020-06-09
Locations: Applied Research Center of Arkansas, Inc., Little Rock, Arkansas, 72212, United States|Clinical Research of South Florida, Coral Gables, Florida, 33134, United States|The Community Research of South Florida, Hialeah, Florida, 33016, United States|Kaohsiung Veterans General Hospital, Kaohsiung, 81362, Taiwan|Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, 833, Taiwan|Chung Shan Medical University Hospital, Taichung, 402, Taiwan|China Medical University Hospital, Taichung, 404, Taiwan|Taichung Veterans General Hospital, Taichung, 40705, Taiwan|Chi-Mei Medical Center, Tainan, 710, Taiwan|National Taiwan University Hospital, Taipei, 10048, Taiwan|Taipei Veterans general Hospital, Taipei, 11217, Taiwan|Tri-Service General Hospital, Taipei, 114, Taiwan|Chang Gung Memorial Hospital_Linkou, Taoyuan, 333, Taiwan
URL: https://clinicaltrials.gov/show/NCT03317028